Items per page
1 - 213 of 213
Title Published in Access level OA Policy Year Views Downloads
Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic toolJournal of neurochemistry
accessLevelPublic
2023 113 59
Oral and intestinal dysbiosis in Parkinson's diseaseRevue neurologique
accessLevelPublic
2023 128 36
Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant FormsFrontiers in immunology
accessLevelPublic
2022 264 109
Assessing preoperative hope and expectations related to functional neurosurgery: a new questionnaireBMC psychology
accessLevelPublic
2022 201 93
Electrophysiological confrontation of Lead-DBS-based electrode localizations in patients with Parkinson's disease undergoing deep brain stimulationNeuroImage. Clinical
accessLevelPublic
2022 181 93
Longitudinal study of speech and dual-task performance in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulationParkinsonism & related disorders
accessLevelPublic
2022 181 70
Oral dysbiosis and inflammation in Parkinson's diseaseJournal of Parkinson's Disease
accessLevelPublic
2021 328 759
Robot-induced hallucinations in Parkinson's disease depend on altered sensorimotor processing in fronto-temporal networkScience Translational Medicine
accessLevelRestricted
2021 238 1
Characterisation of advanced Parkinson's disease: OBSERVE-PD observational study – results of the Swiss subgroupSwiss Medical Weekly
accessLevelPublic
2021 171 80
Geospatial analysis of individual-based Parkinson's disease data supports a link with air pollution: a case-control studyParkinsonism & Related Disorders
accessLevelPublic
2021 273 87
Multiomic Analyses of Dopaminergic Neurons Isolated from Human Substantia Nigra in Parkinson's Disease: A Descriptive and Exploratory StudyCellular and molecular neurobiology
accessLevelPublic
2021 233 168
Sensitivity and specificity of an acoustic- and perceptual-based tool for assessing motor speech disorders in French: the MonPaGe-screening protocolClinical Linguistics and Phonetics
accessLevelPublic
2021 245 453
Embarrassment and Shame in People With Parkinson's Disease: A New Tool for Self-AssessmentFrontiers in Neurology
accessLevelPublic
2020 212 124
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohortBMC Neurology
accessLevelPublic
2020 300 118
Illness representations and coping strategies in patients treated with deep brain stimulation for Parkinson's diseaseJournal of Clinical Medicine
accessLevelPublic
2020 414 156
Modeling of electric fields in individual imaging atlas for capsular threshold prediction of deep brain stimulation in Parkinson's disease: a pilot studyFrontiers in Neurology
accessLevelPublic
2020 226 108
Extrastriatal 123I-FP-CIT SPECT impairment in degenerative parkinsonismsParkinsonism & Related Disorders
accessLevelRestricted
2020 405 1
Complex movement disorder in a patient with heterozygous YY1 mutation (Gabriele-de Vries syndrome)American Journal of Medical Genetics. A
accessLevelRestricted
2020 310 1
Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic NeuronsStem Cells and Development
accessLevelPrivate
2020 298 1
Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD)Molecular Imaging and Biology
accessLevelRestricted
2020 327 0
Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's diseaseMovement Disorders
accessLevelRestricted
2019 413 2
Education level affects dual-task gait after deep brain stimulation in Parkinson's diseaseParkinsonism & Related Disorders
accessLevelRestricted
2019 368 1
Patient-adjusted deep-brain stimulation programming is time saving in dystonia patientsJournal of Neurology
accessLevelRestricted
2019 363 0
Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indicesJournal of Neurology
accessLevelPublic
2019 389 166
Recent developments in drug-induced movement disorders: a mixed pictureThe Lancet Neurology
accessLevelRestricted
2019 346 1
An Empirical Study on the Application of the Burden of Normality to Patients Undergoing Deep Brain Stimulation for Parkinson's DiseaseJournal of Psychosocial Rehabilitation and Mental Health
accessLevelPublic
2019 321 201
The Burden of Normality as a Model of Psychosocial Adjustment After Deep Brain Stimulation for Parkinson's Disease: A Systematic InvestigationNeuropsychology
accessLevelPublic
2019 572 343
Treatment of Drug-Induced ParkinsonismTherapy of Movement Disorders: A Case-Based Approach
accessLevelRestricted
2019 348 0
The Impact of Deep Brain Stimulation for Parkinson's Disease on Couple Satisfaction: An 18-Month Longitudinal StudyJournal of Clinical Psychology in Medical Settings
accessLevelPublic
2019 519 165
The role of molecular imaging in assessing degenerative parkinsonism – an updated reviewSwiss Medical Weekly
accessLevelPublic
2018 721 298
What Is the Best Electrophysiologic Marker of the Outcome of Subthalamic Nucleus Stimulation in Parkinson Disease?World Neurosurgery
accessLevelRestricted
2018 412 0
Maladie de Parkinson au stade avancé : indication aux traitements complexesRevue médicale suisse
accessLevelPublic
2018 795 497
Descriptive epidemiology of parkinsonism in the Canton of Geneva, SwitzerlandParkinsonism & Related Disorders
accessLevelRestricted
2018 437 1
Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective studyJournal of the Neurological Sciences
accessLevelRestricted
2018 545 0
Prevalence of functional (psychogenic) parkinsonism in two Swiss movement disorders clinics and review of the literatureJournal of the Neurological Sciences
accessLevelRestricted
2018 430 1
Cas 5 - Addictions comportementales et apathie dans la maladie de Parkinson: d'un extrême à l'autre13 cas cliniques en neuropsychologie des émotions
2018 351 0
Mouvements anormauxRevue médicale suisse
accessLevelPublic
2018 344 109
Mouvements anormaux aux urgencesRevue médicale suisse
accessLevelPublic
2018 531 346
Combined 123I-FP-CIT SPECT semiquantitative and visual assessment in parkinsonian syndromes and dementia with Lewy bodies - response to Kawada et alJournal of the Neurological Sciences
accessLevelRestricted
2018 422 1
Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind studyMovement Disorders
accessLevelRestricted
2018 649 1
123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System AtrophyClinical Nuclear Medicine
accessLevelRestricted
2018 584 6
Consolidation of a Learned Skill Correlates with Dopamine SPECT Uptake in Early Parkinson's DiseaseJournal of Clinical Neurology
accessLevelPublic
2018 474 205
Localization of Deep Brain Stimulation Contacts Using Corticospinal/Corticobulbar Tracts StimulationFrontiers in neurology
accessLevelPublic
2017 520 251
Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicusParkinsonism & related disorders
accessLevelRestricted
2017 605 3
The added value of combined visual and semi-quantitative assessment for (123)I-FP-CIT SPECT and reply to Ueda et alNeurological Sciences
accessLevelRestricted
2017 424 0
Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia AHaemophilia
accessLevelRestricted
2017 376 0
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registryParkinsonism & Related Disorders
accessLevelRestricted
2017 625 0
Added Value of Combined Semi-Quantitative and Visual [123I]FP-CIT SPECT Analyses for the Diagnosis of Dementia With Lewy BodiesClinical nuclear medicine
accessLevelRestricted
2017 582 1
Deep brain stimulation-associated brain tissue imprints: a new in vivo approach to biological research in human Parkinson's diseaseMolecular neurodegeneration
accessLevelPublic
2016 553 275
Discriminating among degenerative parkinsonisms using advanced 123I-ioflupane SPECT analysesNeuroImage. Clinical
accessLevelPublic
2016 659 166
Diabetic Striatopathy in Childhood: A Case ReportPediatrics
accessLevelRestricted
2016 614 1
No more SWEDDsMovement disorders
accessLevelRestricted
2016 502 0
Scan without evidence of dopaminergic deficit: A 10-year retrospective studyParkinsonism & related disorders
accessLevelRestricted
2016 515 0
Establishing On-Site Reference Values for 123I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative ConditionsMolecular imaging and biology
accessLevelRestricted
2016 622 5
Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarctionScientific reports
accessLevelPublic
2016 577 249
Distinct spatiotemporal patterns for disease duration and stage in Parkinson's diseaseEuropean journal of nuclear medicine and molecular imaging
accessLevelRestricted
2016 706 1
Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gaitMovement disorders
accessLevelRestricted
2016 569 1
Diagnostic de la maladie de Parkinson : pas si facile…Revue médicale suisse
accessLevelRestricted
2015 383 1
Stimulation cérébrale profonde et «révolution translationnelle» : le rôle central des cliniciensRevue médicale suisse
accessLevelRestricted
2015 455 0
Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's DiseaseAJOB neuroscience
accessLevelRestricted
2015 618 3
Evaluation of electrode position in deep brain stimulation by image fusion (MRI and CT)Neuroradiology
accessLevelRestricted
2015 618 1
Stimulation cérébrale profonde : passé, présent et avenirRevue médicale suisse
accessLevelRestricted
2015 453 1
Stimulation cérébrale profonde lors de maladie de Parkinson et autres troubles du mouvement : indications, résultats et complicationsRevue médicale suisse
accessLevelRestricted
2015 479 2
Neuropathology of Parkinsonism in Alzheimer's diseaseAdvances in experimental medicine and biology
2015 643 1
E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseasesJournal of inflammation
accessLevelPublic
2015 621 236
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosisProteomics. Clinical applications
accessLevelRestricted
2014 828 12
Proteomics as a new paradigm to tackle Parkinson's disease research challengesTranslational proteomics
accessLevelRestricted
2014 572 0
Neuropathology of Parkinsonism in Patients with Pure Alzheimer's DiseaseJournal of Alzheimer's disease
2014 678 0
Acute and subacute drug-induced movement disordersParkinsonism & related disorders
accessLevelRestricted
2014 611 1
2014 recommendations for the treatment of Parkinson's diseaseSchweizer Archiv für Neurologie und Psychiatrie
accessLevelPublic
2014 648 632
Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesisProteomics
accessLevelRestricted
2014 620 5
Transcranial magnetic resonance imaging-guided focused ultrasound in Parkinson's diseaseSchweizer Archiv für Neurologie und Psychiatrie
accessLevelPublic
2014 482 763
A novel approach to reducing number of sensing units for wearable gait analysis systemsIEEE transactions on biomedical engineering
accessLevelRestricted
2013 614 0
Etiologies of Parkinsonism in a century-long autopsy-based cohortBrain pathology
accessLevelRestricted
2013 650 0
Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial resultsEuropean radiology
accessLevelPublic
2013 681 404
Non-dopaminergic drugs for motor symptomsParkinson's Disease
2013 411 0
Neuropathology of dementia in a large cohort of patients with Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2013 624 0
Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementiaClinical nuclear medicine
accessLevelRestricted
2013 742 3
Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2013 642 1
Characterization of the glycated human cerebrospinal fluid proteomeJournal of proteomics
accessLevelRestricted
2012 612 0
Résistances thérapeutiques dans les mouvements anormauxRevue médicale suisse
accessLevelRestricted
2012 508 0
Delayed leukoencephalopathy after alprazolam and methadone overdose: a case report and review of the literatureClinical neurology and neurosurgery
accessLevelRestricted
2012 623 0
Pilomotor seizure: when paroxysmal gooseflesh heralds brain tumorNeurology
accessLevelRestricted
2012 718 0
Blood glutathione S-transferase-π as a time indicator of stroke onsetPloS one
accessLevelPublic
2012 687 317
Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's diseaseJournal of proteomics
accessLevelRestricted
2012 613 0
Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial resultsAmerican journal of neuroradiology
accessLevelRestricted
2012 633 0
Diagnosis of and treatment for symptomatic carotid stenosis: an updated reviewActa neurologica Scandinavica
accessLevelRestricted
2012 626 0
Comparison of gel-based methods for the detection of cerebrospinal fluid rhinorrheaClinica chimica acta
accessLevelRestricted
2012 586 0
Neuroproteomics and Parkinson's disease: don't forget human samplesExpert review of proteomics
accessLevelPublic
2011 634 356
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosisBMC gastroenterology
accessLevelPublic
2011 700 307
VPS35 mutations in Parkinson diseaseAmerican journal of human genetics
accessLevelPublic
2011 722 717
Brain extracellular fluid protein changes in acute stroke patientsJournal of proteome research
accessLevelRestricted
2011 587 0
From relative to absolute quantification of tryptic peptides with tandem mass tags: application to cerebrospinal fluidChimia
2010 655 0
Levodopa in the treatment of Parkinson's disease: an old drug still going strongClinical interventions in aging
accessLevelPublic
2010 1,026 1,054
Stroke severity and residual flow determined by transcranial colour-coded ultrasound (TCCD) predict recanalization and clinical outcome during thrombolysisJournal of the neurological sciences
accessLevelRestricted
2010 597 0
Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesisExpert review of proteomics
accessLevelPublic
2010 487 732
Giant plexiform neurofibroma in neurofibromatosis type 1Archives of neurology
accessLevelRestricted
2010 607 1
Stratégies thérapeutiques dans la maladie de Parkinson avancéeSchweizer Archiv für Neurologie und Psychiatrie
accessLevelPublic
2010 899 746
Zinc-induced copper deficiency in Wilson diseaseJournal of neurology, neurosurgery and psychiatry
accessLevelRestricted
2010 666 0
Virus, lymphocyte et cerveau : une nouvelle problématique neurologiqueRevue médicale suisse
accessLevelRestricted
2009 428 0
Naloxone-responsive acute dystonia and parkinsonism following general anaesthesiaAnaesthesia
accessLevelRestricted
2009 641 0
Retronasal olfactory function in Parkinson's diseaseThe Laryngoscope
accessLevelRestricted
2009 586 0
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2009 611 0
Restless legs syndrome: an early manifestation of Huntington's disease?Acta neurologica Scandinavica
accessLevelRestricted
2009 650 0
Neuropathological correlates of lower limb corticobasal degenerationNeuropathology and applied neurobiology
accessLevelRestricted
2009 604 0
Autoanticorps en neurologie : implications cliniquesRevue médicale suisse
accessLevelRestricted
2009 535 0
Dyskinesia-induced postural instability in Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2009 522 0
Velocity control in Parkinson's disease: a quantitative analysis of isochrony in scribbling movementsExperimental brain research
accessLevelPublic
2009 579 342
Proteomics in human Parkinson's disease researchJournal of proteomics
accessLevelRestricted
2009 648 0
Pluripotent stem cells as new drugs? The example of Parkinson's diseaseInternational journal of pharmaceutics
accessLevelRestricted
2009 741 3
Foot dystonia as the only manifestation of unilateral nigral atrophyMovement disorders
accessLevelRestricted
2008 582 0
Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effectParkinsonism & related disorders
accessLevelRestricted
2008 611 0
Restless armsLancet
accessLevelRestricted
2008 509 0
Brueghel syndrome as a new manifestation of HIV encephalopathyEuropean neurology
accessLevelRestricted
2008 576 0
L'hystérie : une entité historique, un trouble psychiatrique ou une maladie neurologique ?Revue médicale suisse
2008 668 0
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5Neurology
accessLevelRestricted
2008 617 0
Historique du Service de Neurologie des Hôpitaux Universitaires de GenèveSchweizer Archiv für Neurologie und Psychiatrie
accessLevelRestricted
2008 546 5
NeuropsychiatrieRevue médicale suisse
accessLevelRestricted
2008 504 0
Richtlinien für die Behandlung des idiopathischen ParkinsonsyndromsSchweizer Archiv für Neurologie und Psychiatrie
accessLevelRestricted
2008 543 0
Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulationParkinsonism & related disorders
accessLevelRestricted
2008 453 0
Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndromeClinical science
accessLevelRestricted
2008 740 9
Rhinorrhea and olfaction in Parkinson diseaseNeurology
accessLevelRestricted
2008 593 0
Phantosmias and Parkinson diseaseArchives of neurology
accessLevelRestricted
2008 543 0
Troubles du contrôle des impulsions et maladie de ParkinsonRevue médicale suisse
2008 660 0
Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tagsAnalytical chemistry
accessLevelRestricted
2008 654 0
Human herpesvirus-6 variant A encephalomyelitisNeurology
accessLevelRestricted
2008 646 0
Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantationBone marrow transplantation
accessLevelRestricted
2008 533 0
Compulsive singing: another aspect of punding in Parkinson's diseaseAnnals of neurology
accessLevelRestricted
2007 598 0
Neurologie du système nerveux périphériqueRevue médicale suisse
2007 434 0
Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring systemIEEE transactions on biomedical engineering
accessLevelRestricted
2007 584 0
Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic strokeBiomarker insights
accessLevelRestricted
2007 594 0
Levodopa-induced ocular dyskinesia in Parkinson's diseaseEuropean Journal of Neurology
accessLevelRestricted
2007 551 0
Downbeat nystagmus as a manifestation of intrathecal morphine toxicityEuropean journal of anaesthesiology
accessLevelRestricted
2007 584 0
Clinical assessment of motor function: a processes oriented instrument based on a speed-accuracy trade-off paradigmBehavioural neurology
accessLevelRestricted
2007 550 2
Is cerebral autoregulation impaired in Parkinson's disease? A transcranial Doppler studyJournal of the neurological sciences
accessLevelRestricted
2007 471 0
Expanding the phenotype of fragile X-associated tremor/ataxia syndrome: a new female caseMovement disorders
accessLevelRestricted
2007 582 0
Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's diseaseMovement disorders
accessLevelRestricted
2007 567 0
Ambulatory monitoring of physical activities in patients with Parkinson's diseaseIEEE transactions on biomedical engineering
accessLevelRestricted
2007 545 0
Age-related proteome analysis of the mouse brain: a 2-DE studyProteomics
accessLevelRestricted
2006 608 0
Revisiter les maladies neurodégénérativesRevue médicale suisse
2006 491 0
State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics researchNature protocols
accessLevelRestricted
2006 613 1
Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?Movement disorders
accessLevelRestricted
2006 622 0
Mécanismes pathogéniques des maladies neurodégénératives : l'exemple de la sclérose latérale amyotrophiqueRevue médicale suisse
2006 499 0
Dégénérescence, régénérescence : un espoir thérapeutique pour la maladie de ParkinsonRevue médicale suisse
2006 527 0
Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's DiseaseJournal of chromatography. B
accessLevelRestricted
2006 564 0
Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulationArchives of neurology
accessLevelRestricted
2006 539 0
Fulminant Lewy body diseaseMovement disorders
accessLevelRestricted
2006 629 0
Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluidJournal of proteome research
accessLevelRestricted
2006 646 0
Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?Proteomics
accessLevelRestricted
2005 596 0
Maladie de Wilson : les présentations cliniquesRevue médicale suisse
2005 451 0
Prostaglandin D2 synthase and its post-translational modifications in neurological disordersElectrophoresis
accessLevelRestricted
2005 627 0
Carbamazepine encephalopathy masquerading as Creutzfeldt-Jakob diseaseNeurology
accessLevelRestricted
2005 632 0
Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson diseaseNeurology
accessLevelRestricted
2005 399 1
PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of strokeClinical chemistry
accessLevelRestricted
2005 619 1
Traitement actuel de la maladie de Parkinson : difficultés et controversesRevue médicale suisse
2005 550 0
Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?British journal of dermatology
accessLevelRestricted
2005 571 0
Unis pour le meilleur..Revue médicale suisse
2005 475 0
Suicide after successful deep brain stimulation for movement disordersNeurology
accessLevelRestricted
2004 593 0
Proteomics in clinical neuroscienceBiomedical applications of proteomics
2004 390 0
Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 yearsNeurology
accessLevelRestricted
2004 569 0
Proteomic applications for molecular assessment of Alzheimer's diseaseBiomedical applications of proteomics
2004 385 0
ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic strokeProteomics
accessLevelRestricted
2004 639 0
L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reductionNeurology
accessLevelRestricted
2004 544 0
Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoringIEEE transactions on biomedical engineering
accessLevelRestricted
2004 491 0
Skull base cerebrospinal fluid fistula: a novel detection method based on two-dimensional electrophoresisHead & neck
accessLevelRestricted
2004 522 0
Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot studyMolecular & cellular proteomics
accessLevelRestricted
2004 592 0
Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitationsClinical chemistry and laboratory medicine
2004 566 0
Phenotypic heterogeneity of dopa-responsive dystonia in monozygotic twinsNeurology
accessLevelRestricted
2004 555 0
Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob diseaseProteomics
accessLevelRestricted
2004 626 0
Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegenerationProteomics
accessLevelRestricted
2004 597 0
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonistsMovement disorders
accessLevelRestricted
2004 549 0
Maladie de Parkinson: description d'un programme interdisciplinaire de rééducation fonctionnelle en groupeRevue médicale de la Suisse romande
2003 629 0
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's diseaseProteomics
accessLevelRestricted
2003 635 0
Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degenerationArchives of neurology
accessLevelRestricted
2003 568 0
How do parkinsonian signs return after discontinuation of subthalamic DBS?Neurology
accessLevelRestricted
2003 600 0
Bilateral optic ischemic neuropathy related to chronic hepatitis C-associated anticardiolipin antibodiesEuropean neurology
accessLevelRestricted
2003 536 0
Causes inhabituelles de troubles de la marcheRevue médicale de la Suisse romande
2003 498 0
The effect of aging on postural stability: a cross sectional and longitudinal studyNeurophysiologie clinique
accessLevelRestricted
2003 516 0
Cas quizRevue médicale de la Suisse romande
2003 471 0
ECG artifact due to deep brain stimulationLancet
accessLevelRestricted
2003 497 0
An ambulatory system to quantify bradykinesia and tremor in Parkinson's diseaseITAB 2003: conference proceedings, 4th International IEEE EMBS Special Topic Conference on Information Technology Applications in Biomedicine, 24-26 April 2003, Birmingham, United Kingdom: new solutions for new challenges
2003 375 0
Microembolic signals and carotid plaque morphology: a study of 71 patients with moderate or high grade carotid stenosisActa neurologica Scandinavica
accessLevelRestricted
2003 525 0
A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob diseaseProteomics
accessLevelRestricted
2003 606 0
Voluntarily simulated tremor in normal subjectsClinical neurophysiology
accessLevelRestricted
2002 523 0
Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathyMetabolic brain disease
accessLevelRestricted
2002 568 0
Analxse cinésiologique de la marche et des mouvements anormauxRevue médicale de la Suisse romande
accessLevelRestricted
2002 409 0
Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14Neurology
accessLevelRestricted
2002 551 0
Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patientsNeurology
accessLevelRestricted
2002 486 1
Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changesTransplant international
accessLevelRestricted
2002 643 0
TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapseBehavioral neuroscience
accessLevelRestricted
2002 486 0
Assessing cerebrospinal fluid rhinorrhea: a two-dimensional electrophoresis approachElectrophoresis
accessLevelRestricted
2001 628 1
Encéphalopathie complexe, transitoire et récidivante après résection étendue de l'intestin grêle. Responsabilité du D-LactateRevue neurologique
2001 573 0
Anti-GAD antibodies and breast cancer in a patient with stiff-person syndrome: a puzzling associationEuropean neurology
accessLevelPublic
2001 572 350
CSF detection of the 14-3-3 protein in unselected patients with dementiaNeurology
accessLevelRestricted
2001 544 0
Lower limb corticobasal degenerationEuropean neurology
accessLevelRestricted
2000 548 0
Bilateral subdural hematomas following routine lumbar diskectomyHeadache
accessLevelRestricted
2000 477 0
Epilepsia cursiva. The forgotten running fitsEuropean neurology
accessLevelRestricted
2000 480 0
Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterationsDigestive diseases and sciences
accessLevelRestricted
2000 521 0
Proximal myotonic myopathy: clinical, electrophysiological and pathological findings in a familyEuropean neurology
accessLevelRestricted
2000 515 0
Olanzapine-induced neuroleptic malignant syndromeArchives of general psychiatry
accessLevelRestricted
1999 545 0
Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental methodMovement disorders
accessLevelRestricted
1999 513 0
Plant-induced seizures: reappearance of an old problemJournal of neurology
accessLevelRestricted
1999 633 0
Tolcapone and fulminant hepatitisLancet
accessLevelRestricted
1998 542 0
Stereotactically guided thalamotomy for treatment of parkinsonian tremor isolated to the lower extremity. Case reportJournal of neurosurgery
accessLevelRestricted
1998 447 0
Effet du traitement antirétroviral sur les manifestations électroencéphalographiques et otoneurologiques précoces de l'infection à VIH et signification pronostique des perturbations constatéesNeurophysiologie clinique
accessLevelRestricted
1997 530 1
Discrepancies between HMPAO and ECD SPECT imaging in brain tumorsThe Journal of nuclear medicine
accessLevelPublic
1997 571 197
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM intervalAmerican journal of human genetics
accessLevelPublic
1996 485 318
Paralysie faciale périphérique isolée et infection à VIH: 7 casRevue neurologique
1995 561 0
Ischaemic colitis due to mitochondrial cytopathyLancet
accessLevelRestricted
1995 537 0
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndromeMedicine
accessLevelRestricted
1992 574 0
A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infectionThe New England journal of medicine
accessLevelRestricted
1990 588 0
Photogenic seizures starting with myoclonias without EEG translationReflex seizures and reflex epilepsies: International Symposium on Reflex seizures and Reflex epilepsies, Genève, Suisse, 3-4 juin 1988
1989 396 0
EEG dans 19 cas de SIDA avec atteinte de l'encéphaleNeurophysiologie clinique
accessLevelRestricted
1988 580 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack